BMO initiates Pfizer at outperform, says Covid drugs and strong pipeline will boost pharma stock

A person walks past the Pfizer Headquarters building in New York, December 7, 2020.

Carlo Allegri | Reuters

The trend of strong drug development and stock outperformance should continue for Pfizer, making it a smart bet for investors, according to BMO Capital Markets.

Leave a Reply

Your email address will not be published. Required fields are marked *